Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience

Pediatric Blood & Cancer(2020)10.1002/pbc.28843Source: DataRank Database

Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience is a research paper published in Pediatric Blood & Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 119 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access119 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.84)OA: bronzeTopics (48)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Joanna Pierro ORCID,Jordan Musante,Prachi Kothari,Bradley Gampel,Burton Appel

Live enrichment

PubMed:33338306 OpenAlex:https://openalex.org/W3111325108

NCI NIH HHS

Grant: P30 CA008748

NCI NIH HHS

Grant: P30 CA016087

NCI NIH HHS

Grant: CA98543

NIH HHS

Grant: R01 CA140729-05

FWCI

6.84

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.28843

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.28843

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28843

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/pbc.28843

journalhttps://doi.org/10.1002/pbc.28843

Fields of Study

COVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesKawasaki Disease and Coronary ComplicationsAdolescentAntineoplastic AgentsCOVID-19ChildChild, PreschoolFemaleHumansMaleNeoplasmsRetrospective StudiesRisk FactorsSARS-CoV-2Severity of Illness Index

MeSH Terms

COVID-19SARS-CoV-2AdolescentAntineoplastic AgentsChildChild, PreschoolFemaleHumansMaleNeoplasmsRetrospective StudiesRisk FactorsSeverity of Illness Index

Keywords

MedicineDiseasePediatric oncologyPandemicRetrospective cohort studyInternal medicineCoronavirus disease 2019 (COVID-19)Pediatric cancerCancerPopulationPediatricsCohortChemotherapyIntensive care medicineInfectious disease (medical specialty)COVID-19SARS-CoV-2immunocompromisedimmunotherapy

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Immunophenotype of lymphocytes and real-world outcome of COVID-19 infection in children with hematology and oncology

10.6084/m9.figshare.26713604.v1figshare

Additional file 1 of Immunophenotype of lymphocytes and real-world outcome of COVID-19 infection in children with hematology and oncology

10.6084/m9.figshare.26713604figshare